🌟 As we bid farewell to #ESMO2023 Congress, we are brimming with inspiration and insight. These days gathered minds from around the globe, fostering collaborations that will shape the future of #oncology. From groundbreaking research to enlightening debates, ESMO - European Society for Medical Oncology Congress has been a testament to the relentless pursuit of medical excellence. Thank you to all who have made this event exceptional. Your contributions, dedication, and passion have been the driving force behind ESMO's resounding success. Keep the conversation, collaboration, and innovation going. Until next time, stay curious, passionate, and committed to making a difference. 🌎 #OncologyInnovation #MedicalResearch #HealthcareAdvancements #MedicalEducation
Amidst the dynamic discussions at #ESMO2023, we take this opportunity to share an innovative case study that delves into the world of #ProstateCancer management. Prostate cancer is a complex disease, and personalized treatment could be critical. This new in-depth study aims to categorize CaP patients by risk and predict biochemical recurrence (BCR) at ten years post-diagnosis by combining MRI and radiomics techniques. What we discovered: 🎯 Radiomic features can predict prognosis. 🌟 Imaging biomarkers have substantial predictive power (AUC > 0.725). 💡 The potential skyrockets when combined with clinical data (AUC 0.841-0.877). Click here to access the complete case study: https://bit.ly/3s583CU ESMO - European Society for Medical Oncology #PrecisionMedicine #CancerResearch #HealthInnovation #MedicalAdvancesProstate
🌟 First day at ESMO - European Society for Medical Oncology Congress, and we're ready for intensive sessions around oncology innovation. Our team is ready to delve into innovative ideas, network with other thought leaders, and explore the latest advances in oncology care. 🤝 Are you here in Madrid? Stop by booth #708! Discover how our cutting-edge #AI technologies empower oncologists with precise insights, reshaping early detection, refining treatment strategies, and monitoring progress, ultimately elevating the quality of #patient #care. Stay tuned for the latest updates. #ESMO2023 #CancerCare #DigitalHealth #InnovationCancer #QuibimAtESMO
Anticipating an exchange of knowledge and insights at the ESMO - European Society for Medical Oncology Congress starting tomorrow, we are proud of sharing an introductory discussion article about our latest research publication in the esteemed Cancers MDPI journal. The study enlightens the potential of MRI-derived imaging biomarker profiles in enhancing PCa risk stratification and biochemical recurrence (BCR) prediction. It's been proved that imaging biomarker profiles help distinguish patients based on risk and BCR occurrence a decade post-diagnosis and that the integration of clinical data notably improves BCR prediction accuracy. Also this article shows how personalized treatment strategies are an excellent starting point to reduce the risks of over or under-treatment. We invite you to explore more of the findings to enhance the standard of care in PCa management here: https://bit.ly/3S0UY8b. #ProstateCancer #Oncology #Radiomics #MRI #CancerResearch #PrecisionMedicine #BCRPrediction #RiskStratification
Quality in healthcare is not just an aspiration; it is an essential commitment that requires collective effort and continuous improvement. 🏥 We are committed to contributing to the pursuit of excellence in #healthcare through innovative solutions. Joining healthcare providers and professionals, we are raising the standard of care for patients worldwide. 💙 Let's mark this #HealthcareQualityWeek as a reminder of our responsibility to ensure daily quality healthcare. 🌐 #HQW #MedicalImaging #PatientCare #Quality
The countdown to #ESMO2023 is officially on! Join the Quibim team in Madrid from October 20-24, where we'll unite with clinicians, researchers, advocates, and industry leaders worldwide. ESMO 2023 is about sharing the latest findings, acquiring world-class knowledge, and seizing every networking opportunity. Join us at booth #708 and check out our three published abstracts: - A clinico-imaging predictive AI model for relapse in colon cancer using baseline CT scans (Abstract 6689 / Poster 579). - CT-based radiomics models that anticipate progression in head and neck cancer post-definitive chemoradiation (Abstract 6850 / Poster 889). - MR imaging biomarker insights for prostate cancer patients on androgen deprivation therapy (Abstract 7180 / Poster 162). https://goo.su/EhpVo Let's explore, connect, and immerse into the hot topics in medical #oncology - stay tuned as we bring you the future of oncology innovation! 🙌
As #ESMO2023 approaches, it's the perfect time to revisit our insightful conversation with the medical oncologist and esteemed institution president, Dr. andres cervantes! Our recent blog, "AI and Precision Health: A Vision of Integrative and Democratized Cancer Care", is a must-read as we delve into the innovative technologies driving the future of #cancer care. Gain deep insight and explore the transformative potential of #AI and #PrecisionMedicine to reshape the healthcare landscape. Don't miss this enriching article! 👉 https://bit.ly/3PPEkp9 You can also watch the full interview here: https://lnkd.in/dJPerNyP
Being recognized among other significant players in the industry for our commitment to advancing healthcare technology is a true honor. We thank our incredible team, partners, and customers who make our innovative work possible. Your dedication to improving #healthcare through technology is what propels us forward. Congratulations to Cleerly for winning the award for "Best Use of AI in Healthcare Technology"! After The Digital Health Hub Foundation and Digital Health Awards we're more motivated than ever to continue our mission of advancing healthcare through cutting-edge technology 🌟
📖 Introducing the Quibim playbook to shine on our path to a successful company culture! This comes from our tireless commitment to refining and enriching our culture, transforming it into our DNA. Today, we are delighted to share it with all of you!
Did you miss our latest webinar "Cancer Immunotherapy: Exploring imaging as a catalyst to immune response prediction?" Don't worry! You can catch up on some of the key insights and discoveries about the future of immunotherapy and its integration with advanced imaging techniques. 🚀 Check out the recording here: bit.ly/3ZbkQQe.
